An infant formula botulism testing petition is now before the Food and Drug Administration, and its author wants to hear from everyone with a stake in keeping babies safe. The petition asks the FDA to add botulism to the agency’s list of organisms for which infant formula must be tested — a change advocates say would close a dangerous gap in how the nation’s most vulnerable consumers are protected.
The petition does not ask the FDA to ban any product or brand. Instead, it seeks a testing requirement: finished-product and ingredient screening for the botulism organism, with the argument that no new law is needed because the list is the FDA’s own and the Commissioner can amend it.
The petition lays out a detailed testing framework. Among its provisions: a finished-product plan built around thirty 200-gram samples, ingredient testing with a defined list of dairy ingredients, an exemption for ingredients that have gone through a validated spore-reduction process, farm-level traceability requirements, and environmental monitoring as a secondary control.
The proposal also has a congressional dimension. S. 272, which passed the Senate unanimously in April, requires one-business-day notice for any organism on the FDA’s testing list. Adding botulism to the list would automatically extend that rapid-notice requirement to it — meaning contamination findings would have to be reported within a day.
The petition’s author notes that the approach draws on recent experience: plant testing by formula maker ByHeart found nothing in environmental monitoring, a data point the petition cites in discussing whether the environmental provisions are appropriately calibrated.
In a publisher’s platform column, the petition’s author has invited comments from scientists, laboratories, public health officials, formula manufacturers, dairy processors, pediatricians and parents. The questions posed are technical and practical: Is thirty 200-gram samples the right finished-product plan, and is it workable at commercial scale? Is the list of dairy ingredients right? Is the exemption for validated spore-reduction processes drawn correctly? Is farm-level traceability practical, and what would it take?
The author also asks what data on cost, laboratory capacity or method performance should be in the record — and, in a notable display of candor, what information unfavorable to the petition might be missing. Edits and redlines are welcome, and a Word version is available on request. Comments should be emailed by Friday, October 30, 2026.
The author notes taking the same approach with a raw-milk cheese warning-label petition and a sprout warning-label petition, and says the comments made both documents better. “Babies cannot read a label or be warned,” the author writes. “The testing has to happen before the can is opened.”
Infant formula occupies a uniquely sensitive position in food safety. For many babies, it is the sole source of nutrition during the most vulnerable months of life, and the consequences of contamination can be catastrophic. The US formula supply has faced repeated scrutiny in recent years — from the 2022 shortage crisis to ongoing concerns about manufacturing oversight — and each episode has intensified pressure on the FDA to strengthen its regulatory framework.
Botulism, caused by Clostridium botulinum, is among the most feared foodborne hazards precisely because of its severity. Infant botulism — typically associated with honey rather than formula — can cause muscle weakness, breathing difficulty and, in severe cases, death. Whether the organism poses a meaningful risk in powdered formula manufacturing is one of the scientific questions the comment process is meant to illuminate.
The petition’s emphasis on testing rather than bans reflects a pragmatic regulatory philosophy: build the safety net into the manufacturing process itself, so hazards are caught before products reach shelves. If the FDA grants the petition, infant formula would join the short list of foods subject to some of the most rigorous pathogen testing in the American food supply — a fitting status, advocates argue, for the food that feeds babies who cannot protect themselves.
Web story: Petition Asks FDA to Test Infant Formula for Botulism